『Medical Economics Pulse』のカバーアート

Medical Economics Pulse

Medical Economics Pulse

著者： Medical Economics Pulse
無料で聴く

このコンテンツについて

 Medical Economics Pulse is a quick-hitting news podcast that keeps physicians in the know. Each episode lasts only a few minutes and delivers concise updates on the most important developments affecting your practice, your bottom line, and the broader health care landscape, delivered to you by the Medical Economics staff editors. From policy changes and reimbursement news to emerging trends and technologies, we distill the most critical headlines into an easy-to-digest format. Stay informed, save time, and gain the insights you need to navigate the business of medicine — all in under five minutes. 政治・政府 衛生・健康的な生活 身体的病い・疾患
エピソード
  • 21: The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

    21: The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment
    2025/06/11
    In this episode of Weekly Dose, we cover the latest clinical research, including a study linking cannabis-related ED visits to a higher risk of dementia, and new findings on hormonal contraceptives and postpartum depression. We also explore the FDA’s approval of the first blood test for Alzheimer disease diagnosis, gepotidacin as an oral treatment for gonorrhea, and the growing global burden of atopic dermatitis in older adults. Tune in for a comprehensive overview of these important studies and their clinical implications.
    続きを読む 一部表示
    5 分
  • 20: Weekly Dose from Patient Care Online: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

    20: Weekly Dose from Patient Care Online: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship
    2025/06/04
    In this episode of Weekly Dose, we round up the latest clinical research, featuring key studies on patient navigation for follow-up colonoscopy, the FDA-approved Teal Wand for at-home cervical cancer screening, and the effectiveness of telemedicine in managing acute respiratory tract infections. We also explore the real-world data on upadacitinib for Crohn disease and the impact of AI in improving mammography accuracy. Tune in for a comprehensive look at these groundbreaking studies and their implications for clinical practice.
    続きを読む 一部表示
    5 分
  • 19: The Weekly Dose from Patient Care: How Medicaid Policies Impact Postpartum Depression Care

    19: The Weekly Dose from Patient Care: How Medicaid Policies Impact Postpartum Depression Care
    2025/05/22
    In this episode of The Weekly Dose, Patient Care editors speaks with Elizabeth Mollard, PhD, about new research she presented at the 2025 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting that highlighted how Medicaid policy directly impacts postpartum depression (PPD) diagnosis rates. Drawing on national data, Mollard explains that more generous Medicaid coverage—especially extended postpartum eligibility—leads to more frequent diagnoses of PPD, a finding that underscores the critical importance of access to care. The conversation covers clinical implications, the effects of the COVID-19-era Medicaid expansion and wind-down, and practical recommendations for clinicians and policymakers to improve mental health outcomes for postpartum patients.

    Key Points:

    • More robust Medicaid coverage leads to higher rates of PPD diagnosis.
      This is not indicative of higher prevalence, but rather of improved access and identification of women in need of care.

    • Medicaid policy changes during the COVID-19 pandemic offer a natural experiment.
      When postpartum Medicaid coverage was expanded nationally, diagnosis rates rose. After the expansion ended, diagnoses dropped—likely due to decreased access, not decreased incidence.

    • Universal screening should be standard clinical practice.
      Mollard recommends screening beyond the six-week postpartum visit and ensuring continuity of care for those who screen positive.

    • Medicaid must support a full range of postpartum mental health services.
      Coverage should include not only screening, but also counseling, medications like zuranolone, and extended eligibility through 12 months postpartum.

    • Policy gaps leave many women uninsured at a vulnerable time.
      Many working women earn too much to qualify for Medicaid but too little to afford private insurance, making extended postpartum coverage essential to reduce disparities and prevent worsening mental health outcomes.
    続きを読む 一部表示
    5 分

Medical Economics Pulseに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。